Levostar Biotech
We provide leading edge services and products supporting the development of cell and gene therapies, and RNA drugs
We provide leading edge services and products supporting the development of cell and gene therapies, and RNA drugs
LevoStar Bio is a biotechnology company with a focus on the production and testing of cell and gene therapy products. Established in 2021 in China, the company's offerings include traceability compliance services, plasmid and mRNA production, CGT analytical testing services, and ready-to-use products. Their slogan, "Innovative Technology for Innovative Therapy," reflects their commitment to pioneering technologies and comprehensive solutions within the cell and gene therapy sector.
As of now, there is no publicly disclosed information about LevoStar Bio's last investment or the involved investors. However, the company's significant contributions to the rapidly evolving field of biotechnology and healthcare make it an entity worth monitoring for potential investment opportunities in the future.
There is no investment information
No recent news or press coverage available for Levostar Biotech.
We care about your data, and we'd love to use cookies make your experience better.